Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.

Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.

Item
http://www.wikidata.org/entity/Q38547265
Proteogenomic studies on cancer drug resistance: towards biomarker discovery and target identification.The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy.Onco-proteogenomics: Multi-omics level data integration for accurate phenotype prediction.Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.Threonine versus isothreonine in synthetic peptides analyzed by high-resolution liquid chromatography/tandem mass spectrometry.Towards a better cancer precision medicine: systems biology meets immunotherapy.Trial watch: DNA-based vaccines for oncological indicationsMHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design
P2860

Proteogenomics meets cancer immunology: mass spectrometric discovery and analysis of neoantigens.

Item
http://www.wikidata.org/entity/Q38547265
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Proteogenomics meets cancer im ...... y and analysis of neoantigens.
@en
type
label
Proteogenomics meets cancer im ...... y and analysis of neoantigens.
@en
prefLabel
Proteogenomics meets cancer im ...... y and analysis of neoantigens.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Proteogenomics meets cancer im ...... y and analysis of neoantigens.
@en
P2093
P2860
P304
P31
P356
10.1586/14789450.2015.1070100
P433
P478
P577
P698